ZUG, SWITZERLAND AND VILNIUS, LITHUANIA / ACCESS Newswire / March 4, 2025 / Micreos Pharmaceuticals AG ("Micreos"), a preclinical-stage ...

Leveraging Northway Biotech's 20+ years of CDMO expertise, Kaida BioPharma is advancing KAD101, a targeted therapy for hormone-driven ovarian cancer WALTHAM, MASSACHUSETTS / ACCESS Newswire / May ...

In a sign of the importance of some of the imports and the damaging effect disruption could have on China's healthcare ...

(Reuters) -Amgen on Friday announced a $900 million expansion of its Ohio biotech manufacturing facility, becoming the latest in a string of drugmakers pledging to increase U.S. capacity amid ...

Debut is dipping its toes into the contract manufacturing business, with the goal of bringing biotech ingredients to the masses. After witnessing an increase in demand, especially among midsize ...

Amgen, Fujifilm Diosynth, Seqiris and Janssen Pharmaceuticals have together already invested billions of dollars to expand biotech manufacturing to the town in recent years. State of play ...

At the top of the list is a mandate for the Food and Drug Administration to reduce the amount of time it takes to approve domestic pharmaceutical manufacturing plants. The agency is being directed ...

For more information, please visit kaida-biopharma.com. Northway Biotech is a leading contract development and manufacturing organization (CDMO) supporting customers worldwide. Its highly ...

(Reuters) -Amgen on Friday announced a $900 million expansion of its Ohio biotech manufacturing facility, becoming the latest in a string of drugmakers pledging to increase U.S. capacity amid ...

Northway Biotech Enters Manufacturing Agreement With Kaida BioPharma for Lead Oncology Program KAD101 ACCESS Newswire. Updated May 21, 2025 8:23 AM.

Northway Biotech Enters Manufacturing Agreement With Kaida BioPharma for Lead Oncology Program KAD101 ACCESS Newswire. Updated May 21, 2025 8:23 AM.